about
Dendritic Cell Targeting mRNA Lipopolyplexes Combine Strong Antitumor T-Cell Immunity with Improved Inflammatory SafetyHeterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase IITargeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancerPrecise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancerPublisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancerAuthor Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-4626-2343
@en
name
Kevin Van der Jeught
@ast
Kevin Van der Jeught
@en
Kevin Van der Jeught
@es
Kevin Van der Jeught
@nl
type
label
Kevin Van der Jeught
@ast
Kevin Van der Jeught
@en
Kevin Van der Jeught
@es
Kevin Van der Jeught
@nl
prefLabel
Kevin Van der Jeught
@ast
Kevin Van der Jeught
@en
Kevin Van der Jeught
@es
Kevin Van der Jeught
@nl
P106
P21
P31
P496
0000-0002-4626-2343